Early research (Phase 1)Looking for participantsNCT06825559
What this trial is testing
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Who this might be right for
Cholestatic Liver Disease
Zydus Therapeutics Inc. 6